Latest News
|
20 November 2012
0 Likes 
What's next for the White House's Office of Information and Regulatory Affairs (OIRA)? The agency, a sub-agency of the Office of Management and Budget (OMB), is sometimes referred to as the regulator
Read More...
Latest News
|
27 September 2012
0 Likes
US President Barack Obama has signed into law three pieces of legislation that affect—directly or indirectly—the activities of the US Food and Drug Administration.User Fees Front and CenterThe first,
Read More...
Latest News
|
17 September 2012
0 Likes
The US Food and Drug Administration (FDA) stands to lose more than $300 million in funding and industry-paid user fees under a budget sequestration process scheduled to come into effect in January
Read More...
Latest News
|
8 August 2012
0 Likes
Officials at the US Food and Drug Administration (FDA) may soon have a better sense of the impact of an upcoming budget sequestration measure thanks to a new piece of legislation signed into law 7
Read More...
Latest News
|
3 August 2012
0 Likes
Cass Sunstein, the high-profile director of the Office of Management and Budget's (OMB) Office of Information and Regulatory Affairs (OIRA), is set to resign from his position as the US' regulatory
Read More...
Latest News
|
10 July 2012
0 Likes
US President Barack Obama signed the Food and Drug Administration Safety and Innovation Act (FDASIA) into law on 9 July 2012—12 days after the Senate approved the bill and 17 days after the House of
Read More...
Latest News
|
27 June 2012
0 Likes
Legislation and executive actions taken in recent years are increasingly looking to regulatory policy as a mechanism for promoting efficiency within the federal bureaucracy and competitiveness in the
Read More...
Latest News
|
31 May 2012
1 Likes
A Republican-led investigation into then-secret negotiations between the Obama Administration and the Pharmaceutical Research and Manufacturers of America (PhRMA) has released its preliminary results,
Read More...
Latest News
|
17 May 2012
0 Likes
The Obama Administration has indicated it “strongly supports passage” of user fee legislation currently in the US Senate, saying it will “help speed safe and effective drugs, medical devices and
Read More...
Latest News
|
14 May 2012
0 Likes
A new bill proposed in the US House of Representatives would require the Office of Information and Regulatory Affairs (OIRA) to compile a report every four years recommending certain regulatory
Read More...